RAB42 overexpression is significantly correlated with weakly infiltrated macrophages, CD8+ and CD4+ T cells, neutrophils, Tregs and dendritic cells across various cancer types (Figure 4A; Supplementary Figures S5A, B). Here, RAB42 is linked to cancer.